Multimedia
Nanotechnology to end insulin injections
UCSF's Tejal Desai describes how she has used nanotechnology to create an artificial pancreas.
Stem cell research could help aging muscles
Irina Conboy describes how stem cells may be used to rebuild muscle tissue after damage from exercise.
Stem cells allow drug trials in a dish
QB3 researcher Bruce Conklin and colleagues are working with a technique that could soon revolutionize the way new medicines are developed. By using stem cells, they are conducting what amounts to human drug trials in a dish.
Cost-effective healthcare conference
On November 18, 2009, UCSF Mission Bay hosted a conference on cost-effective healthcare. Keynote speakers included Steve Burd, CEO of Safeway, and Andy Grove, former CEO of Intel.
Biotalk with QB3's Doug Crawford
Doug Crawford talks to Ron Leuty of the San Francisco Business Times about the QB3 Garage at UCSF.
Robotic cells to fight cancer tumors
Wendell Lim describes how he is engineering cells to carry and deliver chemotherapeutic drugs to tumors.
Elizabeth Blackburn wins Nobel Prize
UCSF's Elizabeth Blackburn, a QB3 researcher, shared the 2009 Nobel Prize for Physiology or Medicine.
Dial “D” for diagnosis
UC Berkeley bioengineering graduate student David Breslauer demonstrates QB3 professor Dan Fletcher's "Cellscope," a handheld microscope fitted to a cellphone that can be used for remote diagnosis.
Bay Area scientists work to unravel H1N1 flu
Charles Chiu, director of UCSF's Viral Diagnostics and Discovery Center, talks about how he is using the ViroChip to track the H1N1 influenza virus as it mutates.
Decoding synthetic biology
QB3 scientists illustrate how the new science of synthetic biology makes biology easier to engineer so that new functions can be derived from living systems.
Medicine from the ocean floor
Scientists at UC Santa Cruz are using robots to sort through thousands of marine chemicals in search of cures for diseases like cholera, breast cancer, and malaria.
Jay Keasling on the Colbert Report
In an appearance on Comedy Central's "The Colbert Report," Berkeley chemical engineering professor Jay Keasling explains how he and his colleagues at the Joint BioEnergy Institute are engineering bacteria to produce fuel from sugar, as well as to synthesize a low-cost anti-malarial drug.
The Gavin Newsom Show
Mayor Gavin Newsom of San Francisco hosts a roundtable about the future of the biotech industry. His guests are Corey Goodman, President of Pfizer's Biotherapeutics and Bioinnovation Center and Regis Kelly, Director of California Institute for Quantitative Biosciences (QB3).
CIRM major facilities speed science and create jobs
David Schaffer, associate director of the Berkeley Stem Cell Center, talks about stem cell research at UC Berkeley and how funds from CIRM are helping build improved research facilities in the Li Ka Shing Center for Biomedical and Health Sciences.
Frontiers in cancer diagnostics: Chipping away at cancer
UCSF professor Joseph DeRisi describes genomic alterations that occur in cancer cells, and how genomic technologies can use this information for diagnostic and therapeutic management.
Living longer, living better
UCSF professor Elizabeth Blackburn explores the effects of aging on a cellular level.
Anticipating synthetic biology
Synberc researchers Paul Rabinow and Drew Endy feature on NPR's Science Friday program.
Growing energy
An episode of the PBS series e2: Energy, which includes an interview with Steve Chu, examines what can be learned from Brazil's extraordinary success with ethanol.
Going green: UC Berkeley leads the way
UC Berkeley has taken global warming and environmental protection seriously, establishing several new energy-related research centers, including the new Energy Biosciences Institute, which will focus on better technologies for producing biofuels – fuels made from plants.
Stanley Hall
Officially dedicated on Friday, September 28, 2007, Stanley Hall represents the promise of a new era in interdisciplinary bioscience research at UC Berkeley.
Follow us on Twitter